This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site



Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyOff-contract claimsAlliance Healthcare

Example content



AMSAMSAn introduction to antimicrobial stewardshipStewardshipSurveillanceRace against resistanceABSABSABS in practice Educational ResourcesAFSAFSShape the futureAFS in practiceImplementing an AFS programmeDiagnosticsGuidelinesCase studiesAll case studiesOur CommitmentOur CommitmentOur commitment to anti-infectivesHeritageSustainability
Our work in the community
Support & ResourcesSupport & ResourcesVideosMaterialsOnline LearningOnline LearningHomeINSPIRE To: Change the CourseLondon AMS SeriesNorth West England AMS SeriesInfectious Thinking Podcasts

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

                                            Online Learning
                                     North West AMS Series

Online Learning Modules

Antimicrobial Stewardship (AMS) in the North West of England

Welcome to the North West AMS Series! 

In this 4 part video series, you'll hear the leading experts from the North-West of England who share their patient case studies and practical approach on implementing antimicrobial stewardship (AMS) into everyday practice. This series takes a closer look at human behaviours and diversity of prescribing. At the end of the series you will be able to download a certificate of completion. 

Introduction to Practical Approaches to AMS in the North-West of England  (10 mins)
By Dr Chris Kosmidis  
The Phenomenology of Anti-Infective use in Haemato-Oncology: The Interface with Infection Specialists 
(14 minutes)
By Dr Chris Eades  
Dr Chris Kosmidis
Infectious Diseases Consultant
Manchester University NHS Foundation Trust

In this webinar, Dr Chris Kosmidis reflects on the origins and increasing prominence of antimicrobial stewardship in the literature and guidance globally, reflecting on its relevance to the North-West of England with its high volume of carbapenem resistant Gram-negative bacteria. Dr Chris shares free resources that are available, including the World Health Organization (WHO) Aware classification of antibiotics.  

Dr Chris Eades MSc MRCP(UK) FRCPath​
The University of Manchester, Department of Infectious Diseases, & Manchester University NHS Foundation Trust 

In this webinar, Dr Chris Eades explores haemato-oncology as a high impact area for anti-infectives due to the complexity of high-risk patients. The presentation includes the historical context of how haemato-oncology and infection services have worked together in the UK, how psychological and behavioral sciences impact prescribing behaviours.

Dr Chris briefly explains phenomenological research methods and how they can be used to understand how anti-infectives are used. Sharing the results of his analysis, the objective is to improve the integration of specialist infection services within haemato-oncology.

Case Study: Patient centred AMS at Manchester University Hospital Foundation Trust (11 mins)
By Ms. Jake Clark 
Patient Case Study: AMS - Right Patient, Right Drug, Right Time (12 mins)By Dr Elizabeth Thursby 
Ms. Jade Clarke, Antimicrobial Pharmacist​ in Manchester

In this webinar, Antimicrobial Stewardship Pharmacist Jade Clarke explains the importance of patient centred stewardship and the practical approaches Manchester University Hospital Foundation Trust have taken to optimise their AMS strategy. Jade shares their Trust's stewardship structure and why she thinks collaboration with stakeholders across the structure and Trust is important for patient outcomes and AMS. The impact of COVID-19 on AMS activities and prescribing is also discussed. 

Dr Elizabeth Thursby
Principal Clinical Scientist​
Wirral University Teaching Hospital NHS Foundation Trust
In this webinar, Dr Elizabeth Thursday shares her experience of treating a patient with Zavicefta (ceftazidime and avibactam). Dr Elizabeth discusses the considerations and rationale of her prescribing decision from a diagnostic, host, pathogen and sensitivity perspective.


Download your certificate here

Thank you for taking time to watch our North West AMS Series! Sign in to download a certificate to demonstrate your completion.


Adverse events should be reported. Reporting forms and information can be found at or search 

for MHRA Yellow Card in Google Play or Apple App Store


Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ


Copyright © 2023 Pfizer Limited. All rights reserved.


VAT registration number GB201048427

PP-UNP-GBR-4885. May 2023
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
You are now leaving PfizerPro
​​​​​​​You are now leaving Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021